Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allarity Therapeutics (ALLR) Interest Expenses (2024 - 2025)

Allarity Therapeutics' Interest Expenses history spans 2 years, with the latest figure at $59000.0 for Q4 2025.

  • For Q4 2025, Interest Expenses fell 21.33% year-over-year to $59000.0; the TTM value through Dec 2025 reached $185000.0, down 71.67%, while the annual FY2025 figure was $185000.0, 71.67% down from the prior year.
  • Interest Expenses reached $59000.0 in Q4 2025 per ALLR's latest filing, up from $57000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $426000.0 in Q2 2024 to a low of $12000.0 in Q2 2025.